IL-17 has a key role during endotoxemia and sepsis, evidenced by the finding that antibody blockade of IL-17 reduces mortality following lethal LPS administration or cecal ligation and puncture (CLP; Flierl et al., 2008; Bosmann et al., 2012). The gene discussed is IL17A; the disease is Sepsis.